Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
01/2004
01/01/2004US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents
01/01/2004US20040002424 2-Amino-4-bicyclylamino-6H-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators
12/2003
12/31/2003WO2004000831A1 Indole derivatives useful as histamine h3 antagonists
12/31/2003WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/31/2003WO2004000817A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003WO2004000816A1 Androgen receptor agonist
12/31/2003WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors
12/31/2003WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
12/31/2003WO2004000806A1 Amides of cyclic amino acids used as pde 4 inhibitors
12/31/2003WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators
12/31/2003WO2004000779A1 Process for producing phenyloxocarboxylic ester derivative
12/31/2003WO2004000230A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
12/31/2003CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound
12/31/2003CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
12/31/2003CA2490043A1 8-(biaryl) quinoline pde4 inhibitors
12/31/2003CA2489815A1 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670388 Antibiotics for Gram positive and Gram negative bacteria; 5-(2-chloro- 5-hydroxybenzyloxy)-1-((2-thiophen-3-yl)ethyl) -1H-indole-2-carboxylic acid; 1-((6-chlorobenzo(1,3)dioxol-5 -yl)methyl)-5-(2-chloro-5-hydroxybenzyloxy)-1H-indole-2-acid
12/30/2003US6670385 α-phenyl-βketosulfone
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670358 Substituted thioacetamides
12/30/2003CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia
12/25/2003WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
12/25/2003US20030236421 Aromatic carboxylic acid bicyclic sulfur compounds
12/25/2003US20030236417 A 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid or ester derivatives, use as iron metabolic chelators in therapeutic applications; demetallization
12/25/2003US20030236410 Cis-4-benzoylamino-6-cyano-or -6-acetyl-3,4-dihydro-2,2-dimethyl-2H- benzo(b)pyran-3-ol, therapeutic agents as anticonvulsants; chemical intermediates from a trans configuration compounds
12/25/2003US20030236406 Amination forming a benzylammonium methyl phenoxy 5-tetrahydrobenzothiepine; apical sodium co- dependent bile acid transporter inhibitors, anticholesterol agents
12/25/2003US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones
12/25/2003US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS
12/25/2003US20030236294 Anticancer agents
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236262 Dietetics; antidiabetic agents; sexual disorders
12/25/2003US20030236261 Potassium channel inhibitors
12/25/2003US20030236256 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
12/25/2003US20030236254 Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/25/2003US20030236251 Hepatitis virus viricides
12/25/2003US20030236198 For treatment of infections by drug resistant bacteria
12/24/2003WO2003106628A2 Benzodiazepine inhibitors of mitochondial f>10< atp hydrolase and methods of inhibiting f>10< atp hydrolase
12/24/2003WO2003106452A2 Antagonists of melanin concentrating hormone receptor
12/24/2003WO2003106451A1 Substituted diaminopyrimidines
12/24/2003WO2003106443A1 1-phenylalkyl-piperazines
12/24/2003WO2003106435A1 Fused-ring pyrimidin-4(3h)-one derivatives, processes for the preparation and uses thereof
12/24/2003WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003WO2003106430A1 Benzimidazole inhibitors of poly(adp-ribosyl) polymerase
12/24/2003WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents
12/24/2003WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003105855A1 Mitotic kinesin inhibitors
12/24/2003WO2003105850A1 2-aminoquinolines as melanin concentrating hormone receptor antagonists
12/24/2003WO2003105849A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
12/24/2003WO2003105847A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003105781A2 Ophthalmic compositions for treating ocular hypertension
12/24/2003WO2003105779A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders
12/24/2003WO2003074529A3 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
12/24/2003WO2003074492A3 5-substituted-alkylaminopyrazole derivatives as pesticides
12/24/2003WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/24/2003WO2003037886A3 Heteroaromatic carboxamide derivatives for the treatment of inflammation
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy
12/24/2003CN1131854C 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives as tachykinin receptor antagonists
12/24/2003CA2489458A1 Substituted diaminopyrimidines
12/24/2003CA2489449A1 1-phenylalkyl-piperazines
12/24/2003CA2489447A1 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/24/2003CA2488845A1 Opthalmic compositions containing selective m1 muscarinic agonists for treating ocular hypertension
12/24/2003CA2488802A1 Ophthalmic compositions for treating ocular hypertension
12/24/2003CA2488606A1 2,5-disubstituted 3-mercaptopentanoic acid
12/24/2003CA2488407A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex
12/24/2003CA2487122A1 Guanidine compounds as anesthetics and for treatment of nervous system disorders
12/23/2003US6667336 Phenyl-thienyl-prop-1-en-3-yl-sarcosine derivatives; nontoxic; neurological and neuropsychiatric disorders; glycine transporter sequestering
12/23/2003US6667326 Thienyl, thiazolyl, isothiazolyl or thiadiazoyl derivatives
12/23/2003US6667319 Neuropeptide Y Y5 receptor antagonists
12/23/2003US6667318 LFA-1 antagonist compounds
12/23/2003US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders
12/23/2003CA2307080C Process for preparing 8-cyclopentyl-6-ethyl-3-¬substituted|-5,8-dihydro-4h-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/23/2003CA2059063C Novel antiviral compounds
12/18/2003WO2003104236A1 Calcitonin gene related peptide receptor antagonists
12/18/2003WO2003104222A1 Bisindolyl-maleimid derivatives as kinase inhibitors
12/18/2003WO2003104217A2 Prodrugs of excitatory amino acids
12/18/2003WO2003104216A1 Urotensin ii receptor modulators
12/18/2003WO2003104198A1 Chemokine receptor antagonist
12/18/2003WO2003104193A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/18/2003WO2003103677A1 Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors
12/18/2003WO2003103669A1 1-(4-piperidinyl) benzimidazolones as histamine h3 antagonists
12/18/2003WO2003103663A2 Substituted pyrrolines as kinase inhibitors
12/18/2003WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/18/2003WO2003066630A3 Quinolinone derivatives for treating cell proliferation related disorders
12/18/2003WO2003051306A3 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
12/18/2003WO2003032072A3 Crosslinkable monomers for novel nonlinear optical polymers
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/18/2003US20030232860 Medicine comprising dicyanopyridine derivative
12/18/2003US20030232853 Azabicyclic compounds for the treatment of disease
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 523